# AngioDynamics, Inc. (NASDAQ: ANGO), Glens Falls, NY – FDA Inspections

Source: https://www.keypedia.com/companies/angiodynamics-inc/1bc90c7f-6a45-49ef-a2a5-fc38418e84aa

> Inspection records and compliance data for AngioDynamics, Inc. in Glens Falls, New York. 10 FDA inspections on record (1 OAI), last inspected June 25, 2021. Publicly traded as NASDAQ: ANGO.

---

## Details

- Name: AngioDynamics, Inc.
- FEI Number: 3017892510
- Address Line 1: 8 Glens Falls Tech Park
- City: Glens Falls
- State: New York
- Zip Code: 12801
- Country Name: United States
- Address: 8 Glens Falls Tech Park, Glens Falls, New York 12801, United States
- Country: United States

## Stock

- Stock ticker: ANGO
- Exchange: NASDAQ
- Share price: $11.99
- Market cap: $504.0M
- Price as of: November 13, 2026

## Related Documents

- [483 - AngioDynamics, Inc. - 2021-06-25](https://www.keypedia.com/records/483/angiodynamics-inc/3055a81f-4efe-4136-a0fb-4e1d80ae4983) — source: FDA, date: June 25, 2021
- FDA Inspection 1145201 - AngioDynamics, Inc. - 2021-06-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 25, 2021
- FDA Inspection 1145201 - AngioDynamics, Inc. - 2021-06-25 — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2021
- FDA Inspection 967909 - AngioDynamics, Inc. - 2016-04-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2016
- [FDA Inspection 967909 - AngioDynamics, Inc. - 2016-04-15](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/bed8ea25-4767-4a2b-b999-2ac3fb6aac39) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2016
- FDA Inspection 941614 - AngioDynamics, Inc. - 2015-08-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 13, 2015
- FDA Inspection 887029 - AngioDynamics, Inc. - 2014-07-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2014
- [FDA Inspection 887029 - AngioDynamics, Inc. - 2014-07-15](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/e71a6b7e-20d5-4ce0-b3b4-e6a54c13983e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2014
- [FDA Inspection 866897 - AngioDynamics, Inc. - 2014-03-30](https://www.keypedia.com/records/fda_inspections/angiodynamics-inc/fd3df1f1-07d6-46d1-afb0-173bdb3091dd) — classification: Official Action Indicated (OAI), source: FDA, date: March 30, 2014
- FDA Inspection 866897 - AngioDynamics, Inc. - 2014-03-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2014
- FDA Inspection 828384 - AngioDynamics, Inc. - 2012-11-28 — classification: No Action Indicated (NAI), source: FDA, date: November 28, 2012

## Related Companies

- [Boston Scientific Corporation](https://www.keypedia.com/companies/boston-scientific-corporation/7b03f40b-d516-4bcb-9702-929c6f485000)
- [Omega Medical Imaging, Inc.](https://www.keypedia.com/companies/omega-medical-imaging-inc/74d04b67-394a-442a-b4f2-08d3f58760c3)
- [Ventana Medical Systems, Inc.](https://www.keypedia.com/companies/ventana-medical-systems-inc/fbee7b78-8ed8-4956-853d-aae637e77eab)
- [Abbott](https://www.keypedia.com/companies/abbott/b7d5749c-5854-4f4a-ad2f-fd6002f0d9fe)
- [Edwards Lifesciences, LLC](https://www.keypedia.com/companies/edwards-lifesciences-llc/33cf0071-5dab-4e01-8479-22f60c63e818)
- [Physio-Control, Inc.](https://www.keypedia.com/companies/physio-control-inc/cd3b1656-c525-4cfe-a3f2-d32143e20c7c)
- [Xintec Corp](https://www.keypedia.com/companies/xintec-corp/68cff15b-7e97-469a-bba5-602f16256f3f)
- [Focus Medical, LLC](https://www.keypedia.com/companies/focus-medical-llc/dc3869e7-ddde-4fb3-bf78-b606df8ae023)
- [DSM Biomedical, Inc.](https://www.keypedia.com/companies/dsm-biomedical-inc/7a6db46d-6f3e-4e92-8fde-1d4f124bdc5e)
- [Invacare Corporation](https://www.keypedia.com/companies/invacare-corporation/ce6ef1ad-105f-4eb0-b2a1-46530b41907a)

## Related Officers

- [Matthew D. Schnittker](https://www.keypedia.com/people/matthew-d-schnittker/cf76f07f-db6d-47a0-8412-7eb084d4fe8b)
